ICON PLC (ICLR) vs Revvity Inc. (RVTY)

ICON PLC and Revvity Inc. are both Diagnostics & Research companies. Revvity Inc. is the larger, with a market value of $16.8B against $15.1B — 1.1× the size. ICON PLC trades at the lower P/E: 34.5× against 71.9×. Revvity Inc. grew revenue faster over the last twelve months: 4.56% against 1.82%. Revvity Inc. has the higher net margin (8.61% vs 5.45%) and the lower return on invested capital (2.50% vs 3.84%). Across the 22 metrics below, ICON PLC leads on 13 and Revvity Inc. on 9.

Valuation

Metric ICLR RVTY Diagnostics & Research median
P/E 34.48 71.89 34.52
P/S 1.88 5.73 4.24
P/B 1.70 2.33 3.42
Price to free cash flow 18.10 28.19 33.51
EV/EBITDA 17.86 25.08 23.44
EV/Sales 2.35 6.61 5.18
Earnings yield 2.90% 1.39% (1.50%)
Free cash flow yield 5.53% 3.55% 0.00%

Profitability

Metric ICLR RVTY Diagnostics & Research median
Gross margin 23.43% 55.91% 48.32%
Operating margin 8.72% 12.65% (5.68%)
Net margin 5.45% 8.61% (4.10%)
Free cash flow margin 10.41% 20.48% 0.00%
Return on equity 4.86% 0.00% 0.00%
Return on assets 2.74% 2.14% (6.05%)
Return on invested capital 3.84% 2.50% 0.00%

Growth

Metric ICLR RVTY Diagnostics & Research median
Revenue growth (TTM) 1.82% 4.56% 8.99%
EPS growth (last fiscal year) (67.42%) (5.91%) 20.36%
Revenue growth, 5-year CAGR 24.15% 1.41% 7.30%
Net income growth, 5-year CAGR (7.15%) (19.82%) 0.00%

Health

Metric ICLR RVTY Diagnostics & Research median
Debt to equity 0.37 0.36 0.01
Current ratio 1.32 2.65 2.27
Net debt to EBITDA 3.34 3.00 0.68

Dividend

Metric ICLR RVTY Diagnostics & Research median
Dividend yield — 0.19% 0.67%
Payout ratio — 0.12 0.20

Size

Metric ICLR RVTY Diagnostics & Research median
Market cap 15.11b 16.83b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack